Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report 2021-04-29 20:30
GenScript Launches Research-Grade Lentiviral Vector Packaging Service 2021-04-28 19:30
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi 2021-04-27 15:53
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-04-26 20:00
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis 2021-04-26 19:00
Wuxi Strives to Build a World-class Biomedical Industry Chain 2021-04-22 19:06
ATH434 protects brain cells and improves motor function in Parkinsonian disorder 2021-04-21 20:11
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research 2021-04-21 20:00
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life." 2021-04-21 19:00
China Biologic Announces Completion of Going Private Transaction 2021-04-21 04:30
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005 2021-04-20 20:54
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration 2021-04-20 08:30
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform 2021-04-20 05:00
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection 2021-04-19 20:15
Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy 2021-04-19 20:00
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC 2021-04-19 20:00
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer 2021-04-19 08:00
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting 2021-04-16 08:00
New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry 2021-04-15 21:00
1 113 114 115 116 117 227